Bonn [Germany]: Infectious agents are fought off by the innate immune system. Interferon, an alarm messenger, is essential in this. It can, however, result in autoimmune disorders if it is created in the absence of an infection. By examining the uncommon autoimmune condition Aicardi-Goutieres syndrome, researchers at the University Hospital Bonn (UKB) and the Technical University (TU) Dresden have looked into an underlying mechanism and determined what motivates unregulated interferon production. The study has now been published in the Journal of Experimental Medicine (JEM).
If our innate immune system recognizes viral genetic information by means of sensors, the alarm messenger type I interferon is produced. It is a very strong activator of immune cells and therefore essential in the defense against many pathogens, not only viruses. However, if too much interferon is produced, or if it is produced for too long, the overactivated immune system attacks healthy cells - collateral damage to what is actually a good immune response.
In addition, the viral genetic information for the sensors looks for the most part like our own DNA and RNA. In order to prevent such false recognition of our own genetic material, there are safety mechanisms in every cell. If these fail, interferon production occurs in the absence of viral infection leading to inflammation.
This sterile inflammation, driven by uncontrolled innate immune activation, has been identified as one factor driving diseases like collagenoses such as Systemic Lupus Erythematosus (SLE). "Diseases like lupus are difficult to study because many genes are involved. But the mechanism of interferon production as a result of the recognition of cell's own nucleic acids also occurs in rare monogenetic autoimmune diseases and in which it can be precisely assigned to a gene defect," said Prof. Dr. Rayk Behrendt, research group leader of the Institute of Clinical Chemistry and Clinical Pharmacology at UKB.
Recognition of DNA and RNA in cells is coupled:The research team from the medical faculties of the University of Bonn and the Technical University of Dresden took advantage of this and took a closer look at Aicardi-Goutieres syndrome in a mouse model. This interferon-driven monogenetic autoimmune disease is triggered by inactivating mutations in genes that degrade cellular nucleic acids and thus prevent sensors of the innate immune system from being overactivated. One of these genes is called SAMHD1, and it regulates the replication and repair of DNA in the cell nucleus.